Evidence map›Paper›PMID 27637878›Full record

ArticleApplied and environmental microbiology2016

Generation of a Stable Plasmid for

Christina N Krute, Kelsey L Krausz, Mary A Markiewicz, Jason A Joyner, Srijana Pokhrel, Pamela R Hall, Jeffrey L Bose

Abstract read
In one paragraph

Article in Applied and environmental microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Mislocalization of PBPs inMicrobiology spectrum · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Control of morphogenesis during theScience advances · 2025
    Article
  7. Article
  8. Article
  9. YjbH contributes toVirulence · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Toolbox of Characterized Genetic Parts forACS synthetic biology · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. The identification of two M20B family peptidases required for full virulence inFrontiers in cellular and infection microbiology · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Christina N KruteDepartment of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Kelsey L KrauszDepartment of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Mary A MarkiewiczDepartment of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Jason A JoynerDepartment of Pharmaceutical Sciences, University of New Mexico College of Pharmacy, Albuquerque, New Mexico, USA.
Srijana PokhrelDepartment of Pharmaceutical Sciences, University of New Mexico College of Pharmacy, Albuquerque, New Mexico, USA.
Pamela R HallDepartment of Pharmaceutical Sciences, University of New Mexico College of Pharmacy, Albuquerque, New Mexico, USA.
Jeffrey L BoseDepartment of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, Kansas City, Kansas, USA jbose@kumc.edu.

Funding

Novel Approaches for the Control of Microbial PathogensP30GM103326 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI LUTKENHAUS, JOSEPH F · 2012 to 2016
$5.3M
Apolipoprotein B and Control of S. aureus Quorum SensingR01AI091917 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI HALL, PAMELA RANEL · 2011 to 2015
$1.9M
Mechanistic control of metabolism and virulence by fatty acid kinase in MRSAR01AI121073 · NIAID · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BOSE, JEFFREY LEE · 2016 to 2020
$1.9M
VLP-based Vaccines for Targeting Staphylococcus aureus Secreted Virulence FactorsR21AI114706 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI HALL, PAMELA RANEL · 2015 to 2016
$416k
NIAID NIH HHS R01 AI091917NIAID NIH HHS R01 AI121073NIAID NIH HHS R21 AI114706NIGMS NIH HHS P30 GM103326
6 · The paper itself

Abstract

A major shortcoming to plasmid-based genetic tools is the necessity of using antibiotics to ensure plasmid maintenance. While selectable markers are very powerful, their use is not always practical, such as during

Identifiers

PMID27637878
PMCPMC5103085

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.